You are here

Cardiovascular Research

Find a Doctor

Saint Luke's Mid America Heart Institute:

  • Is participating in close to 180 clinical research trials in all aspects of cardiovascular disease—far more than any other hospital in Kansas City.
  • Was named one of only four national Outcomes Research Centers by the American Heart Association. Together, the centers have created a national network for cardiovascular and stroke research.
  • Serves as a national model for developing successful research programs.
  • Is a national leader in cardiovascular research, with three clinical studies recognized on the American Heart Association's Top 10 list of scientific advances in heart disease and stroke.

Innovation has always been the focus at Saint Luke’s Mid America Heart Institute since its founding more than 25 years ago. As the nation’s first heart hospital, and a part of the premier health system in the Kansas City region, Saint Luke’s Mid America Heart Institute has earned a worldwide reputation for excellence in the treatment of cardiovascular disease.

Today Saint Luke’s Mid America Heart Institute is a recognized leader in many areas of cardiovascular clinical research. These programs, which enroll hundreds of patients annually in a wide array of randomized trials and registry-based research studies, are essential to our mission. Research allows us to remain on the leading edge of cardiovascular medicine, providing our patients with the most current treatments and medications.

Many of our cardiologists participate in research through the Ben D. McCallister Clinical Scholars Program, which provides funding and support for investigator initiated research.

An Unprecedented ‘Triple Play’

The three most important general medical journals in the world are the New England Journal of Medicine, the Journal of the American Medical Association (JAMA), and The Lancet. Although most researchers would be thrilled to publish a paper in one of these major journals during their careers, in 2013, the cardiovascular research program at MAHI was fortunate to have three papers published during a single week – one in each of these highly prestigious journals. Paul Chan, M.D., directed a study investigating long-term outcomes among patients who survive an episode of in-hospital cardiac arrest that was published in the New England Journal of Medicine. Adnan Chhatriwalla, M.D., and Steven Marso, M.D., conducted a study of more than 1 million patients undergoing percutaneous coronary revascularization that explored the contribution of post-procedural bleeding to subsequent in-hospital mortality that was published in JAMA. And concurrently, Randall Thompson, M.D., directed an important study exploring the origins of atherosclerosis in early humans based on findings from CT scans of mummies collected from around the globe, the results of which were published in The Lancet. The simultaneous publication of these three studies, each led by MAHI investigators is testimony to the breadth, depth, and worldwide recognition of the quality of the science being led by our talented investigators.

Centers of excellence 

In addition to participating in numerous multicenter clinical trials, Saint Luke’s cardiovascular research encompasses centers of excellence in cardiovascular outcomes research, health economics and technology assessment, noninvasive cardiac imaging, and intravascular ultrasound. These centers of excellence direct independent research and collaborate with top researchers around the world.

The most rewarding benefit of this commitment to research is seeing how it translates into the highest quality of care at the patient’s bedside. This is where research, innovation, and compassion come together in an unrivaled combination for the benefit of our patients and their families.

Areas of cardiovascular research include:

Saint Luke's Mid America Heart Institute 2013 research facts

  • 179 active studies
  • 1,277 patients enrolled
  • 150 publications
  • 226 abstracts/presentations

Contact us

Saint Luke's Mid America Heart Institute 
Cardiovascular Research
4401 Wornall Road
Kansas City, MO 64111
(816) 932-4581

Cardiovascular Research
Saint Luke's Mid America Heart Institute

4401 Wornall Road
Kansas City, MO 64111
(816) 932-4581


  • Omega-3 and Prostate Cancer  Examining the Pertinent Evidence

    Saint Luke’s Mid America Heart Institute experts smelled something fishy when recent media reports warned of eating fish or fish oil supplements.

  • Hear Michael Main, M.D., discuss the current tools available for treating heart disease as well as the current heart research and clinical trials taking place at Saint Luke's Mid America Heart Institute.